<DOC>
	<DOCNO>NCT00034827</DOCNO>
	<brief_summary>CI-1040 experimental drug test patient advanced colorectal lung cancer fail one prior chemotherapy regimen , breast cancer fail 2 prior regimen patient pancreatic cancer receive prior chemotherapy . CI-1040 take orally twice daily meal . Patients require blood test periodically receive treatment monitor closely throughout trial possible side effect response .</brief_summary>
	<brief_title>A Multicenter Phase 2 Study CI-1040 Patients With Advanced Nonsmall-Cell Lung , Breast , Colon Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Patients least 18 year old pathological hiostological confirmation colorectal , nonsmall cell lung cancer , breast , pancreas cancer . No 1 prior chemo lung colon cancer , 2 breast prior chemotherapy pancreas cancer . Original recent tumor tissue must available . Patients must prior chemoptherapy 4 week radiation 3 week . Patients must adequate renal , liver , bone marrow function , serious infection lifethreatening illness ( unrelated tumor ) . Must able swallow capsule gastrointestinal disorder may affect absorption drug . Unstable medical condition prior chemotherapy within 4 week screen series infection tumor type ECOG performance status 3 4 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>